Sinovac Biotech Ltd. — Operating Income by Fiscal Year
17 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/641afb8c-7b16-4709-a505-e30658514554/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-490.1M | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-258534 |
| FY 2024 | $-505.5M | 2024-01-01 – 2024-12-31 | evidence 0001193125-26-194394 |
| FY 2023 | $-714.0M | 2023-01-01 – 2023-12-31 | evidence 0001193125-26-194394 |
| FY 2022 | $-509.0M | 2022-01-01 – 2022-12-31 | evidence 0001193125-26-194394 |
| FY 2021 | $17.6B | 2021-01-01 – 2021-12-31 | evidence 0001193125-26-194394 |
| FY 2020 | $215.6M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-020156 |
| FY 2019 | $68.6M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-020204 |
| FY 2018 | $45.3M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-013766 |
| FY 2017 | $45.4M | 2017-01-01 – 2017-12-31 | evidence 0001144204-18-027303 |
| FY 2016 | $504.0k | 2016-01-01 – 2016-12-31 | evidence 0001144204-17-060660 |
| FY 2015 | $3.7M | 2015-01-01 – 2015-12-31 | evidence 0001144204-17-060660 |
| FY 2014 | $1.9M | 2014-01-01 – 2014-12-31 | evidence 0001144204-17-060660 |
| FY 2013 | $9.9M | 2013-01-01 – 2013-12-31 | evidence 0001144204-16-096074 |
| FY 2012 | $-21.2M | 2012-01-01 – 2012-12-31 | evidence 0001104659-14-027985 |
| FY 2011 | $3.4M | 2011-01-01 – 2011-12-31 | evidence 0001104659-14-027985 |
| FY 2010 | $-13.4M | 2010-01-01 – 2010-12-31 | evidence 0001104659-13-044076 |
| FY 2009 | $42.1M | 2009-01-01 – 2009-12-31 | evidence 0001104659-12-024859 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).